Roches Tecentriq Subcutaneous Gets Approval in the EU - Zacks Investment Research
| RCGHX Fund | USD 17.07 0.06 0.35% |
Slightly above 55% of Allianzgi Health's investor base is interested to short. The analysis of overall sentiment of trading Allianzgi Health Sciences mutual fund suggests that many investors are impartial at this time. Allianzgi Health's investing sentiment can be driven by a variety of factors including economic data, Allianzgi Health's earnings reports, geopolitical events, and overall market trends.
Allianzgi |
Roches Tecentriq Subcutaneous Gets Approval in the EU Zacks Investment Research
Read at news.google.com
 |
Allianzgi Health Fundamental Analysis
We analyze Allianzgi Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allianzgi Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allianzgi Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Allianzgi Health is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Allianzgi Health Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allianzgi Health mutual fund to make a market-neutral strategy. Peer analysis of Allianzgi Health could also be used in its relative valuation, which is a method of valuing Allianzgi Health by comparing valuation metrics with similar companies.
Peers
Allianzgi Health Related Equities
| CDICX | Calvert Short | 0.00 |
| ||
| QLENX | Aqr Long | 0.00 |
| ||
| TSDCX | Touchstone Ultra | 0.00 |
| ||
| GTLSX | Quantitative Longshort | 0.00 |
| ||
| GDICX | Goldman Sachs | 0.00 |
| ||
| RSDIX | Rbc Short | 0.00 |
| ||
| OWSBX | Old Westbury | 0.00 |
|
Other Information on Investing in Allianzgi Mutual Fund
Allianzgi Health financial ratios help investors to determine whether Allianzgi Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allianzgi with respect to the benefits of owning Allianzgi Health security.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |